纤维化间质性肺疾病患者报告的生活质量：自我管理能力和情感的新评估
Patient-reported quality of life in fibrotic interstitial lung disease: novel assessments of self-management ability and affect.
作者信息
Moua Teng, Kubbara Aahd, Novotny Paul, Ridgeway Jennifer L, Limper Andrew H, Ryu Jay H, Clark Matthew M, Benzo Roberto
机构信息
Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Dept of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
出版信息
ERJ Open Res. 2021 Mar 8;7(1). doi: 10.1183/23120541.00011-2021. eCollection 2021 Jan.
相似文献
1
Patient-reported quality of life in fibrotic interstitial lung disease: novel assessments of self-management ability and affect.纤维化间质性肺疾病患者报告的生活质量：自我管理能力和情感的新评估
ERJ Open Res. 2021 Mar 8;7(1). doi: 10.1183/23120541.00011-2021. eCollection 2021 Jan.
2
Corticosteroid therapy in fibrotic interstitial lung disease: a modified Delphi survey.纤维化间质性肺疾病的皮质类固醇治疗：一项改良德尔菲调查
ERJ Open Res. 2024 Oct 7;10(5). doi: 10.1183/23120541.00561-2024. eCollection 2024 Sep.
3
The "silent threat" of nocturnal hypoxia remains unresolved for patients with fibrotic interstitial lung diseases.对于纤维化间质性肺疾病患者而言，夜间低氧血症这一“无声威胁”仍未得到解决。
ERJ Open Res. 2024 Feb 12;10(1). doi: 10.1183/23120541.01017-2023. eCollection 2024 Jan.
4
The relationship between perceived and performance fatigability in severe fibrotic interstitial lung disease: a prospective, cross-sectional study.重度纤维化间质性肺疾病中感知疲劳与运动表现疲劳之间的关系：一项前瞻性横断面研究。
ERJ Open Res. 2023 May 9;9(3). doi: 10.1183/23120541.00726-2022. eCollection 2023 May.
5
Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new.间质性肺异常是类风湿关节炎间质性肺病进展的危险因素：有哪些新情况。
Breathe (Sheff). 2020 Dec;16(4):200223. doi: 10.1183/20734735.0223-2020.
6
Lung transplantation outcome in adult surfactant-related interstitial lung disease: first evidence to move on.成人表面活性剂相关间质性肺疾病的肺移植结局：前行的首个证据
ERJ Open Res. 2023 Nov 20;9(6). doi: 10.1183/23120541.00646-2023. eCollection 2023 Nov.
7
Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need.纤维化间质性肺疾病患者的支持性护理：满足重大临床需求。
Breathe (Sheff). 2020 Sep;16(3):200066. doi: 10.1183/20734735.0066-2020.
8
Diagnosis and Management of Fibrotic Interstitial Lung Diseases.纤维化间质性肺疾病的诊断与管理。
Clin Chest Med. 2021 Jun;42(2):321-335. doi: 10.1016/j.ccm.2021.03.008.
9
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial.门诊吸氧对肺纤维化疾病患者生活质量的影响（AmbOx）：一项前瞻性、开放标签、混合方法、交叉随机对照试验。
Lancet Respir Med. 2018 Oct;6(10):759-770. doi: 10.1016/S2213-2600(18)30289-3. Epub 2018 Aug 28.
10
Interstitial lung abnormalities: do symptoms matter?间质性肺异常：症状重要吗？
ERJ Open Res. 2023 Sep 25;9(5). doi: 10.1183/23120541.00502-2023. eCollection 2023 Sep.
引用本文的文献
1
Association of Mood or Affect With Respiratory-Related Quality of Life, Lung Function, and All-Cause Mortality in Fibrotic Interstitial Lung Disease.纤维化间质性肺疾病中情绪或情感与呼吸相关生活质量、肺功能及全因死亡率的关联
Mayo Clin Proc Innov Qual Outcomes. 2025 Aug 29;9(5):100660. doi: 10.1016/j.mayocpiqo.2025.100660. eCollection 2025 Oct.
2
Clinical and Functional Outcomes Associated with Quality of Life in Patients with Lymphangioleiomyomatosis: A Cross-Sectional Study.淋巴管肌瘤病患者的临床和功能结局与生活质量相关：一项横断面研究。
Lung. 2024 Dec;202(6):757-765. doi: 10.1007/s00408-024-00751-w. Epub 2024 Oct 14.
3
Association of patient-reported outcome measures with lung function and mortality in fibrotic interstitial lung disease: a prospective cohort study.患者报告结局指标与纤维化间质性肺疾病肺功能及死亡率的关联：一项前瞻性队列研究
ERJ Open Res. 2024 Mar 25;10(2). doi: 10.1183/23120541.00591-2023. eCollection 2024 Mar.
本文引用的文献
1
Fibrosing interstitial lung diseases: knowns and unknowns.纤维性间质性肺疾病：已知与未知。
Eur Respir Rev. 2019 Feb 27;28(151). doi: 10.1183/16000617.0100-2018. Print 2019 Mar 31.
2
Impact of Pulmonary Rehabilitation on Exercise Tolerance and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A SYSTEMATIC REVIEW AND META-ANALYSIS.特发性肺纤维化患者肺康复对运动耐量和生活质量的影响：系统评价和荟萃分析。
J Cardiopulm Rehabil Prev. 2018 Sep;38(5):273-278. doi: 10.1097/HCR.0000000000000273.
3
Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries.未满足的特发性肺纤维化治疗需求——来自五个欧洲国家的患者病历回顾。
BMC Pulm Med. 2017 Sep 15;17(1):124. doi: 10.1186/s12890-017-0468-5.
4
Self-management and quality of life in chronic obstructive pulmonary disease (COPD): The mediating effects of positive affect.慢性阻塞性肺疾病（COPD）的自我管理与生活质量：积极情绪的中介作用
Patient Educ Couns. 2016 Apr;99(4):617-623. doi: 10.1016/j.pec.2015.10.031. Epub 2015 Nov 10.
5
Pulmonary rehabilitation for interstitial lung disease.间质性肺疾病的肺康复治疗
Cochrane Database Syst Rev. 2014 Oct 6(10):CD006322. doi: 10.1002/14651858.CD006322.pub3.
6
How to measure self-management abilities in older people by self-report. The development of the SMAS-30.如何通过自我报告来测量老年人的自我管理能力。SMAS-30量表的编制
Qual Life Res. 2005 Dec;14(10):2215-28. doi: 10.1007/s11136-005-8166-9.
7
Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review.特发性肺纤维化患者的健康相关生活质量：一项系统综述
Thorax. 2005 Jul;60(7):588-94. doi: 10.1136/thx.2004.035220.
8
Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR).自我报告的慢性呼吸问卷（CRQ-SR）的开发。
Thorax. 2001 Dec;56(12):954-9. doi: 10.1136/thorax.56.12.954.
9
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.医学研究委员会（MRC）呼吸困难量表在评估慢性阻塞性肺疾病患者残疾程度方面的实用性。
Thorax. 1999 Jul;54(7):581-6. doi: 10.1136/thx.54.7.581.
10
Development and validation of brief measures of positive and negative affect: the PANAS scales.积极和消极情绪简短测量方法的编制与验证：PANAS量表
J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063.
Zotero 插件